Semaglutide vs Tirzepatide: Which Is Right for You?

Semaglutide and tirzepatide are the two most widely discussed GLP-1 medications for weight management. Both have shown remarkable results in clinical studies, but they work differently and may suit different individuals. This guide breaks down everything you need to know to have an informed conversation with your healthcare provider.

How They Work

Semaglutide

Semaglutide is a GLP-1 receptor agonist — it mimics the hormone GLP-1, which your body naturally produces after eating. This hormone:

• Signals your brain to reduce appetite
• Slows gastric emptying (food stays in your stomach longer)
• Helps regulate blood sugar levels
• Reduces food cravings, particularly for high-calorie foods

Brand names include Ozempic (for type 2 diabetes) and Wegovy (for weight management).

Tirzepatide

Tirzepatide is a dual-action medication — it activates both GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) receptors. This dual mechanism means it:

• Provides all the same appetite-regulating benefits as semaglutide
• Additionally targets GIP receptors for enhanced metabolic effects
• May offer improved blood sugar regulation
• Has shown potentially greater weight reduction in clinical trials

Brand names include Mounjaro (for type 2 diabetes) and Zepbound (for weight management).

Efficacy: What the Research Shows

Both medications have demonstrated significant results in large-scale clinical trials:

Semaglutide (STEP trials):

• Average weight loss of 15-17% of body weight over 68 weeks
• Approximately one-third of participants lost 20% or more
• Significant improvements in cardiovascular risk markers

Tirzepatide (SURMOUNT trials):

• Average weight loss of 18-22% of body weight over 72 weeks
• Over half of participants on the highest dose lost 20% or more
• Notable improvements in metabolic health markers

While tirzepatide has shown slightly higher average weight loss in clinical trials, individual results vary significantly. Your provider can help determine which medication may work best for your specific situation.

Administration

Both medications are administered as once-weekly subcutaneous injections. Key details:

• Frequency: One injection per week for both
• Injection site: Abdomen, thigh, or upper arm
• Dose titration: Both start at lower doses and gradually increase over several weeks
• Semaglutide: Typically starts at 0.25mg, increasing to a maintenance dose of 1.0-2.4mg
• Tirzepatide: Typically starts at 2.5mg, increasing to a maintenance dose of 5-15mg

Common Side Effects

Both medications share similar side effect profiles, primarily gastrointestinal:

• Nausea (most common, usually improves with time)
• Diarrhea or constipation
• Decreased appetite
• Abdominal discomfort
• Injection site reactions

Most side effects are mild to moderate and tend to decrease as your body adjusts. The gradual dose titration schedule is specifically designed to minimize these effects. Your provider will monitor your response and adjust your treatment plan accordingly.

Pricing Comparison (2026)

• Brand-name semaglutide (Wegovy): $900-$1,350/month without insurance
• Brand-name tirzepatide (Zepbound): $1,000-$1,200/month without insurance
• Compounded semaglutide: $179-$299/month through telehealth platforms
• Compounded tirzepatide: $299-$449/month through telehealth platforms

Compounded versions offer the same active ingredients at a fraction of the brand-name cost, prepared by FDA-registered compounding pharmacies.

Who Qualifies?

General eligibility criteria for both medications:

• BMI of 30 or higher, OR
• BMI of 27 or higher with at least one weight-related condition
• No history of medullary thyroid cancer or MEN2 syndrome
• Not currently pregnant or breastfeeding

Your licensed provider will conduct a thorough evaluation to determine which medication is most appropriate for your health profile and goals.

How to Choose

The choice between semaglutide and tirzepatide should be made in consultation with a licensed healthcare provider, based on:

• Your health profile: Medical history, current medications, and specific health conditions
• Your goals: Weight management targets and timeline
• Your budget: Pricing varies between the two medications
• Your response: Some individuals respond better to one than the other
• Provider recommendation: Your provider's clinical judgment based on your complete health picture

The Bottom Line

Both semaglutide and tirzepatide are effective, well-studied medications for weight management. Tirzepatide's dual mechanism has shown slightly higher average results in clinical trials, but individual responses vary. The most important step is connecting with a licensed provider who can evaluate your specific situation and recommend the right approach.